A compound of Formula wherein L is a bond, -CH 2 -, -SO 2 -, -CH 2 -SO 2 -, -SO 2 -CH 2 -, -SO 2 -NR-, -SO 2 -NR-CH 2 -, -CH 2 -SO 2 -NR-, -NR-, -NR-SO 2 -, -NR-SO 2 -NR-, -S-, -S-CH 2 -, -CH 2 -S-, -C(=O)-, -C(=O)-O-, -O-, -O-CH 2 -, -NR-C(=O)-, -NR-C(=O)-NR-, or - C(=O)-NR-, wherein R is H, C 1-2 alkyl, C 1-2 alkyl-OH or cyclopropyl; R 1 is H, or methyl; R 2 is H, cyano, halo, -SO 2 -CH 3, 2-(trimethylsilyl)ethoxy, phenyl, C 1-6 alkyl, heteroaryl, heterocyclyl, C 3-9 cycloalkyl, provided R 2 is not H if L is a bond, and wherein said phenyl, C 1-6 alkyl, heteroaryl, heterocyclyl or C 3-9 cycloalkyl is optionally and independently substituted with 1-4 substituents selected from the group consisting of: methyl, ethyl, oxo, fluoro, hydroxyl, cyano, amino, methoxy, tert -butoxy, acetyl, cyclopropyl, cyclobutyl, cyclohexyl, phenyl, azetidin-1-yl, azetidin-3-yl, pyrrolidin-1-yl, 2,4-dihydro-3 H -1,2,4-triazol-3-one-4-yl, 1 H -imidazol-4-yl, pyrazin-2-yl, pyrimidin-2-yl, 1,3-oxazolidin-2-one-5-yl, N -benzamide, benzo[d]imidazol-2 -one, 4-methylpiperazin-1-yl, morpholin-4-yl, CF 3,-SO 2 -CH 3, -C(=O)-cyclopropyl, -SO 2 -cyclohexyl, -NHCH 3, -N(CH 3) 2, -NHAc, -NHCO 2 t-Bu, -CH 2 -NH 2, -C(=O)-NH 2, -C(=O)-N(ethyl) 2, -NH-C(=O)-NH 2,-NH-C(=O)-CH 3, -C(=O)-(C 1 -C 4 alkyl), -C(=O)-OH, -C(=O)-NH(C 1 -C 4 alkyl)-(CH 2) n -OH, and -(CH 2) n -CN, wherein n is 1 or 2; V is CH, CR', or N, wherein R' is methyl or F; W is CR" or N, wherein R" is H, F, hydroxyl, amino, CH 3 or -O-CH 3; ring A is selected from the group consisting of: R 3 is H, F, methyl, or -O-CH 3; R 3 ' is H or F; R 4 is H, methyl, cyano, amino, halo, -COOH, or -O-CH 3; and R 5 is H, methyl, cyano, or -CF 3; or a pharmaceutically acceptable salt thereof. L is a bond, -CH 2 -, -SO 2 -, -CH 2 -SO 2 -, -SO 2 -CH 2 -, -SO 2 -NR-, -SO 2 -NR-CH 2 -, -CH 2 -SO 2 -NR-, -NR-, -NR-SO 2 -, -NR-SO 2 -NR-, -S-, -S-CH 2 -, -CH 2 -S-, -C(=O)-, -C(=O)-O-, -O-, -O-CH 2 -, -NR-C(=O)-, -NR-C(=O)-NR-, or - C(=O)-NR-, wherein R is H, C 1-2 alkyl, C 1-2 alkyl-OH or cyclopropyl; R 1 is H, or methyl; R 2 is H, cyano, halo, -SO 2 -CH 3, 2-(trimethylsilyl)ethoxy, phenyl, C 1-6 alkyl, heteroaryl, heterocyclyl, C 3-9 cycloalkyl, provided R 2 is not H if L is a bond, and wherein said phenyl, C 1-6 alkyl, heteroaryl, heterocyclyl or C 3-9 cycloalkyl is optionally and independently substituted with 1-4 substituents selected from the group consisting of: methyl, ethyl, oxo, fluoro, hydroxyl, cyano, amino, methoxy, tert -butoxy, acetyl, cyclopropyl, cyclobutyl, cyclohexyl, phenyl, azetidin-1-yl, azetidin-3-yl, pyrrolidin-1-yl, 2,4-dihydro-3 H -1,2,4-triazol-3-one-4-yl, 1 H -imidazol-4-yl, pyrazin-2-yl, pyrimidin-2-yl, 1,3-oxazolidin-2-one-5-yl, N -benzamide, benzo[d]imidazol-2 -one, 4-methylpiperazin-1-yl, morpholin-4-yl, CF 3,-SO 2 -CH 3, -C(=O)-cyclopropyl, -SO 2 -cyclohexyl, -NHCH 3, -N(CH 3) 2, -NHAc, -NHCO 2 t-Bu, -CH 2 -NH 2, -C(=O)-NH 2, -C(=O)-N(ethyl) 2, -NH-C(=O)-NH 2,-NH-C(=O)-CH 3, -C(=O)-(C 1 -C 4 alkyl), -C(=O)-OH, -C(=O)-NH(C 1 -C 4 alkyl)-(CH 2) n -OH, and -(CH 2) n -CN, wherein n is 1 or 2; V is CH, CR', or N, wherein R' is methyl or F; W is CR" or N, wherein R" is H, F, hydroxyl, amino, CH 3 or -O-CH 3; ring A is selected from the group consisting of: R 3 is H, F, methyl, or -O-CH 3; R 3 ' is H or F; R 4 is H, methyl, cyano, amino, halo, -COOH, or -O-CH 3; and R 5 is H, methyl, cyano, or -CF 3; methyl, ethyl, oxo, fluoro, hydroxyl, cyano, amino, methoxy, tert -butoxy, acetyl, cyclopropyl, cyclobutyl, cyclohexyl, phenyl, azetidin-1-yl, azetidin-3-yl, pyrrolidin-1-yl, 2,4-dihydro-3 H -1,2,4-triazol-3-one-4-yl, 1 H -imidazol-4-yl, pyrazin-2-yl, pyrimidin-2-yl, 1,3-oxazolidin-2-one-5-yl, N -benzamide, benzo[d]imidazol-2 -one, 4-methylpiperazin-1-yl, morpholin-4-yl, CF 3,-SO 2 -CH 3, -C(=O)-cyclopropyl, -SO 2 -cyclohexyl, -NHCH 3, -N(CH 3) 2, -NHAc, -NHCO 2 t-Bu, -CH 2 -NH 2, -C(=O)-NH 2, -C(=O)-N(ethyl) 2, -NH-C(=O)-NH 2,-NH-C(=O)-CH 3, -C(=O)-(C 1 -C 4 alkyl), -C(=O)-OH, -C(=O)-NH(C 1 -C 4 alkyl)-(CH 2) n -OH, and -(CH 2) n -CN, wherein n is 1 or 2; V is CH, CR', or N, wherein R' is methyl or F; W is CR" or N, wherein R" is H, F, hydroxyl, amino, CH 3 or -O-CH 3; ring A is selected from the group consisting of: R 3 is H, F, methyl, or -O-CH 3; R 3 ' is H or F; R 4 is H, methyl, cyano, amino, halo, -COOH, or -O-CH 3; and R 5 is H, methyl, cyano, or -CF 3; R 3 is H, F, methyl, or -O-CH 3; R 3 ' is H or F; R 4 is H, methyl, cyano, amino, halo, -COOH, or -O-CH 3; and R 5 is H, methyl, cyano, or -CF 3;